Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information for Common Stock
Our common stock has been listed on the Nasdaq Global Market under the symbol “DIBS” since June 10, 2021. Prior to that date, there was no public trading market for our common stock.
Holders of Record
As of the close of business on February 20, 2026, there were 72 stockholders of record of our common stock. The actual number of holders of our common stock is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers or other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
Dividend Policy
We have never declared or paid cash dividends on our capital stock. We intend to retain all available funds and future earnings and do not anticipate paying cash dividends in the foreseeable future. Any future decision to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable laws and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions, and other factors that our Board of Directors think are relevant.
Sales of Unregistered Equity Securities
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
In August 2023, the Board of Directors authorized the Company to repurchase up to an aggregate of $20.0 million of its common stock (“2023 Stock Repurchase Program”). In June 2024, the Board of Directors authorized an increase to the Company’s 2023 Stock Repurchase Program to an aggregate repurchase amount of $25.5 million, and subsequently announced the completion of its 2023 Stock Repurchase Program. In August 2024, the Board of Directors authorized the Company to repurchase up to an aggregate of $10.0 million of its common stock (“2024 Stock Repurchase Program”). In November 2025, the Company's Board of Directors authorized the Company to repurchase up to an aggregate of $12.0 million of its common stock (“2025 Stock Repurchase Program”). The Board also terminated the 2024 Stock Repurchase Program it previously authorized in August 2024. As of December 31, 2025, 7,238,060 shares have been purchased for a total cost of $35.0 million and approximately $10.4 million remains available for future purchases under the 2025 Stock Repurchase Program.
The following table presents details of our monthly share repurchases for the three months ended December 31, 2025:
Period Total Number of Shares Purchased Average Price Paid per Share (a) Total number of Shares Purchased as Part of Publicly Announced Plans or Programs (b) Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs (in thousands) (c)
October 1, 2025 - October 31, 2025 — $ — — $ 1,999
November 1, 2025 - November 30, 2025 316,546 $ 4.96 316,546 $ 10,428
December 1, 2025 - December 31 2025 — $ — — $ 10,428
Total 316,546 316,546
(a) Average price per share includes broker commissions.
(b) On November 4, 2025, the Board of Directors authorized a 2025 Stock Repurchase Program to repurchase an aggregate of $12.0 million of common stock.
(c) Approximately $2.0 million was remaining in the 2024 Stock Repurchase Program in October 2025 before being replaced by the 2025 Stock Repurchase Program, which increased the total allowable repurchases by an additional $10.0 million.
The Company’s officers and directors are required to comply with the Company’s securities trading policy at all times, including during a repurchase program. The securities trading policy, among other things, prohibits trading in the Company’s securities when in possession of material non-public information and restricts the ability of certain officers or director from transacting in the Company’s securities during specific blackout periods, subject to certain limited exceptions, including transactions pursuant to a Rule 10b5-1 trading plan that complies with the conditions of Rule 10b5-1 of the Exchange Act.
41
Item 6. [Reserved]
42